Yoshikai Y - Search Results

1

Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice.

Harano M, Eto M, Iwai T, Tatsugami K, Kiyoshima K, Kamiryo Y, Tsuneyoshi M, Yoshikai Y, Naito S. Harano M, et al. Among authors: yoshikai y. Cancer Res. 2005 Nov 1;65(21):10032-40. doi: 10.1158/0008-5472.CAN-05-0457. Cancer Res. 2005. PMID: 16267029

2

Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Maeda T, Ando T, Nomoto K. Eto M, et al. Among authors: yoshikai y. J Immunol. 1991 Mar 1;146(5):1402-9. J Immunol. 1991. PMID: 1671578

3

Eto M, Mayumi H, Nishimura Y, Maeda T, Yoshikai Y, Nomoto K. Eto M, et al. Among authors: yoshikai y. J Immunol. 1991 Oct 15;147(8):2439-46. J Immunol. 1991. PMID: 1918974

4

Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nomoto K. Eto M, et al. Among authors: yoshikai y. J Exp Med. 1990 Jan 1;171(1):97-113. doi: 10.1084/jem.171.1.97. J Exp Med. 1990. PMID: 2136907 Free PMC article.

5

Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K. Eto M, et al. Among authors: yoshikai y. J Immunol. 1990 Sep 1;145(5):1303-10. J Immunol. 1990. PMID: 2143514

6

Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.

Tomita Y, Nishimura Y, Harada N, Eto M, Ayukawa K, Yoshikai Y, Nomoto K. Tomita Y, et al. Among authors: yoshikai y. J Immunol. 1990 Dec 15;145(12):4026-36. J Immunol. 1990. PMID: 2147933

7

The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K. Eto M, et al. Among authors: yoshikai y. Eur J Immunol. 1990 Sep;20(9):2005-13. doi: 10.1002/eji.1830200919. Eur J Immunol. 1990. PMID: 2209702

8

Enhanced resistance against Escherichia coli infection by subcutaneous administration of the hot-water extract of Chlorella vulgaris in cyclophosphamide-treated mice.

Konishi F, Tanaka K, Kumamoto S, Hasegawa T, Okuda M, Yano I, Yoshikai Y, Nomoto K. Konishi F, et al. Among authors: yoshikai y. Cancer Immunol Immunother. 1990;32(1):1-7. doi: 10.1007/BF01741717. Cancer Immunol Immunother. 1990. PMID: 2289197 Free PMC article.

9

Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.

Harada M, Matsuzaki G, Yoshikai Y, Kobayashi N, Kurosawa S, Takimoto H, Nomoto K. Harada M, et al. Among authors: yoshikai y. Cancer Res. 1993 Jan 1;53(1):106-11. Cancer Res. 1993. PMID: 8093229

10

Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.

Eto M, Yoshikai Y, Nishimura Y, Hiromatsu K, Maeda T, Nomoto K, Kong YY, Kubo RT, Kumazawa J, Nomoto K. Eto M, et al. Among authors: yoshikai y. Immunology. 1994 Feb;81(2):198-204. Immunology. 1994. PMID: 8157269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters